FDA approves intramuscular injection route of administration of Plegridy for multiple sclerosis – Biogen
Biogen Inc. announced that the FDA has approved a new intramuscular (IM) injection route of administration for Plegridy (peginterferon beta-1a) for the treatment of relapsing forms of multiple… read more.
